Sign in
CompletedNo phase

tDCS and Inhibitory Control in PTSD

Key facts

Who runs it
Gopalkumar Rakesh
Where
Lexington, United StatesSee the site
Trial code
Status
Completed
People taking part
38 people enrolled
Started
27 Oct 2023
Ended
4 Dec 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • tDCS
Record updated
16 January 2025

Who can take part

Age
18 years to 55 years
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Ability to provide informed consent
  • Ability and willingness to perform procedures
  • Age 18-55
  • Female sex
  • Meet diagnostic criteria for past-month probable IPV-related PTSD
  • Medication free or stable (≥4 weeks) medication(s)

Who cannot take part

  • Daily use of psychostimulant medication
  • Unstable medical, psychiatric, or neurological condition that may necessitate urgent treatment
  • History of psychosis, mania, major neurological disorder, significant head trauma, or epilepsy
  • Daily use of medications that significantly lower seizure threshold
  • History of seizures
  • Moderate severity substance-use disorder
  • Contraindications for tDCS
  • Current suicidal intent
  • Current pregnancy

Where in United States

  • University of KentuckyLexington, United States

About the trial

What the trial wants to find out

Large samples (~2,000/yr) of adult undergraduate students at a large southern university will be pre-screened via the University of Kentucky SONA System (IRB#43626) to identify and recruit adult female participants who report a history of IPV and probable PTSD to participate in a one-day lab study. After completing an IRB-approved informed consent, participants will complete a brief psychiatric diagnostic interview and a battery of questionnaires. They will then complete three blocks of the Stop Signal Task (SST). Participants will be randomized (double-blind, stratified by PTSD diagnosis and psychotropic medication use) to receive 15-min of active or sham multifocal tDCS targeting the rIFG. tDCS will be delivered offline for 11.5-mins after block 1 of the SST and online for 3.5-mins during block 2 of the SST. Sham stimulation will be identical to active tDCS, but electrical current will only be ramped in/out at the beginning and end of the 15-mins. The third block of the SST will be completed after tDCS. Lastly, participants will complete a pictorial trauma-related symptom provocation task. Participants will be compensated with course credit.

The 2 groups in the trial

  • Active tDCSExisting treatment, for comparison

    Current will be ramped in/out for 15 seconds at the beginning and end of a 15-minute period and a constant current will be delivered for the 15-minutes between ramping

    Treatment: tDCS

  • Shame tDCSSham treatment, for comparison

    Current will be ramped in/out for 15 seconds at the beginning and end of a 15-minute period during which no stimulation will be delivered.

    Treatment: tDCS

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluating the Impact of Transcranial Direct Current Stimulation on Inhibitory Control in PTSD
Record updated
16 January 2025